首页 > 市场调查报告书 > 医疗设备

e保健 IoT

市场调查报告书

商品编码

1606549

全球医疗物联网 (IoMT) 市场 - 2024-2031

Global Internet of Medical Things (IoMT) Market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023年，全球医疗物联网（IoMT）市场规模达498.2亿美元，预计2031年将达到4,597.8亿美元，2024-2031年预测期间复合年增长率为32.3%。

医疗物联网 (IoMT) 代表了医疗保健领域的一种变革性方法，它整合了透过线上网路连接到医疗保健资讯系统的医疗设备和应用程式网路。这种连接主要透过支援 Wi-Fi 的装置促进机器对机器的通信，这对于 IoMT 的功能至关重要。

IoMT 涵盖各种旨在收集、传输和分析健康资料的智慧医疗设备。这些设备包括远端患者监测 (RPM) 系统、穿戴式健康追踪器和各种临床监测工具。它们在安全网路上运行，允许患者和医疗保健提供者之间进行即时资料交换，从而显着提高医疗机构中的患者护理和运营效率。

市场动态：

驱动程式和限制

穿戴式装置的需求不断增长

穿戴式装置的兴起极大地推动了医疗物联网 (IoMT) 市场的成长，推动了向个人化、预防性和远距医疗保健解决方案的转变。穿戴式设备，包括配备先进感测器的智慧手錶和健身追踪器，透过追踪心率、血压、血氧水平和睡眠模式等生命体征，促进持续的健康监测。这些即时资料使个人能够主动管理慢性病，同时使医疗保健提供者能够提供更有效、数据驱动的护理。

例如，具有心电图监测功能的穿戴式装置可以检测不规则的心律，从而及时进行医疗干预。这些设备对于远端病患监护 (RPM) 至关重要，透过有效远端监测病患状况，有助于将再入院率减少高达 50%。

公司正在将这些先进技术整合到穿戴式装置中，并创新新的解决方案来帮助个人满足其医疗需求。例如，2024 年 11 月，SmartCardia 的 7 导程即时心电图监测贴片和云端平台获得了 FDA 的行动门诊心臟遥测 (OCT/MCT) 许可。 SmartCardia的7L贴片易于配戴、无线、防水，可用于长达14天的连续监测。在此之前，SmartCardia 先前已获得 FDA 批准扩展动态心电图、事件和动态心电图监测。获得批准后，SmartCardia 的解决方案可用于远端即时监测患者心电图，并立即通知临床医生重要的心律不整。

随着对多种疾病的非侵入性管理的需求不断增长，该公司正在推出几种先进的疾病监测解决方案。例如，2024年4月，雷迪博士实验室透过其降级子公司betapharm在德国推出了无药、非侵入性偏头痛管理穿戴式装置Nerivio。

随着感测器技术的不断进步，穿戴式装置变得更加紧凑、精确和多功能，进一步融入更广泛的物联网生态系统。

监管挑战

安全和隐私问题预计将阻碍医疗物联网 (IoMT) 市场的成长。随着物联网设备收集和传输敏感的健康讯息，它们很容易受到网路攻击和资料洩露，这对患者隐私构成严重风险。许多物联网设备缺乏足够的安全措施，通常是由于设计不当或身份验证协定不足，导致它们容易受到各种类型的攻击，包括未经授权的存取和资料操纵。这些挑战不仅威胁到患者的信任，也阻碍了 IoMT 解决方案的广泛采用，最终影响市场成长。

The Internet of Medical Things (IoMT) represents a transformative approach in healthcare, integrating a network of medical devices and applications that connect to healthcare information systems via online networks. This connectivity facilitates machine-to-machine communication, primarily through Wi-Fi-enabled devices, which is essential for the functionality of IoMT.

IoMT encompasses a wide array of smart medical devices designed to collect, transmit, and analyze health data. These devices include remote patient monitoring (RPM) systems, wearable health trackers, and various clinical monitoring tools. They operate on secure networks that allow real-time data exchange between patients and healthcare providers, significantly enhancing patient care and operational efficiency in healthcare settings.

Market Dynamics: Drivers & Restraints

Rising demand for wearable devices

The rise of wearable devices is significantly propelling the growth of the Internet of Medical Things (IoMT) market by promoting a shift towards personalized, preventive, and remote healthcare solutions. Wearables, including smartwatches and fitness trackers equipped with advanced sensors, facilitate continuous health monitoring by tracking vital signs such as heart rate, blood pressure, oxygen levels, and sleep patterns. This real-time data empowers individuals to proactively manage chronic conditions while enabling healthcare providers to offer more effective, data-driven care.

For instance, wearables with ECG monitoring capabilities can detect irregular heart rhythms, prompting timely medical intervention. These devices are crucial in remote patient monitoring (RPM), helping to reduce hospital readmissions by up to 50% through effective distance monitoring of patients' conditions.

Companies are integrating these advanced technologies into wearable devices and are innovating new solutions that help individuals address their medical needs. For instance, in November 2024, SmartCardia received FDA clearance for Mobile Outpatient Cardiac Telemetry (OCT/MCT) for its 7-lead live ECG monitoring patch and cloud platform. SmartCardia's 7L patch is easy to wear, cable-free, waterproof, and can be used for continuous monitoring for up to 14 days. This comes on the heels of SmartCardia's prior FDA clearance for Extended Holter, Event, and Holter monitoring. With this approval, SmartCardia's solution can be used for remote live monitoring of patients' ECG and immediately notify clinicians of important arrhythmias.

With the rising demand for non-invasive management for several diseases, companies are launching several advanced solutions for monitoring the diseases. For instance, in April 2024, Dr. Reddy's Laboratories launched the drug-free, non-invasive migraine management wearable device Nerivio in Germany through its step-down subsidiary, betapharm.

As sensor technology continues to advance, wearables are becoming more compact, accurate, and multifunctional, further integrating into the broader IoMT ecosystem.

Regulatory challenges

Security and privacy concerns are expected to impede the Internet of Medical Things (IoMT) market growth. As IoMT devices gather and transmit sensitive health information, they become vulnerable to cyber-attacks and data breaches, which pose serious risks to patient privacy. Many IoMT devices lack adequate security measures, often due to poor design or insufficient authentication protocols, making them susceptible to various types of attacks, including unauthorized access and data manipulation. These challenges not only threaten patient trust but also impede the widespread adoption of IoMT solutions, ultimately affecting market growth.

Segment Analysis

The global Internet of Medical Things (IoMT) market is segmented based on product type, material, application, end-user, and region.

Product Type:

Hardware segment is expected to dominate the global Internet of Medical Things (IoMT) market share

The hardware segment is expected to hold the dominant position in the global Internet of Medical Things market The growth of the hardware segment in the Internet of Medical Things (IoMT) market is significantly fueled by the increasing demand for connected medical devices that enable real-time monitoring and data collection.

As healthcare providers adopt IoMT solutions to enhance patient care and streamline operations, hardware components become essential in facilitating these capabilities. The integration of advanced sensors and communication technologies within these devices improves their accuracy and reliability, making them indispensable in clinical environments. For instance, in September 2023, Movesense introduced a compact and lightweight wearable electrocardiogram (ECG) sensor for remote patient monitoring and telehealth applications. The 'Movesense Medical sensor is registered as a class IIa device under the European Union (EU) Medical Device Regulation (MDR) and is designed for use by remote healthcare providers, medical device manufacturers and integrators, hospitals, or companies developing their commercialized medical device.

Furthermore, ongoing technological advancements are leading to the development of more compact and efficient hardware solutions. These advanced devices are receiving approvals from the regulatory bodies by meeting the regulations. For instance, in September 2024, Senseonics Holdings, Inc. received the U.S. Food and Drug Administration (FDA) for its next-generation Eversense 365 CGM system for people with Type 1 and Type 2 diabetes aged 18 years and older. Eversense 365 is the world's first One-year CGM system, representing a significant breakthrough in diabetes technology and management. The system also includes a smart transmitter worn over the sensor that sends data to a mobile app on the person's smartphone every 5 minutes. It is removable and can be taken on and off without removing the sensor.

These innovations not only enhance the performance of IoMT devices but also increase their accessibility for healthcare providers across various settings, including hospitals, clinics, and home care environments. As a result, the hardware segment is expected to maintain a dominant position in the IoMT market, driving further adoption of these technologies and improving overall healthcare delivery systems.

Geographical Analysis

North America is expected to hold a significant position in the global Internet of Medical Things (IoMT) market share

North America holds a dominant position in the global Internet of Medical Things (IoMT) market and is expected to hold the major portion of the market during the forecast period. The region's market growth is attributed to the rising technological advancements, increasing demand for wearable

Healthcare providers are increasingly utilizing IoMT solutions to enhance patient monitoring, optimize clinical operations, and improve overall healthcare delivery. The growing acceptance of digital health technologies is significantly contributing to the expansion of the IoMT market. For instance, according to the data provided by the National Institute of Health in 2023, almost 1 in 3 Americans uses a wearable device, such as a smartwatch or band, to track their health and fitness, according to thousands of adults who participated in the Health Information National Trends Survey.

In North America, the rising prevalence of chronic diseases has intensified the demand for remote patient monitoring and connected medical devices. As healthcare providers look for efficient methods to manage these conditions, IoMT solutions have become essential for delivering timely and effective care. For instance, according to the Centers for Disease Control and Prevention, from August 2021 to August 2023, the prevalence of total diabetes was 15.8%, diagnosed diabetes was 11.3%, and undiagnosed diabetes was 4.5% in U.S. adults. The increasing number of individuals with diabetes increases the use of wearable devices that monitor blood glucose levels using sensors.

Additionally, the presence of numerous key players in the region further supports market growth, fostering innovation and competition within the IoMT landscape.

Asia Pacific is growing at the fastest pace in the global Internet of Medical Things (IoMT) market

The Asia-Pacific (APAC) region is emerging as one of the fastest-growing markets in the global Internet of Medical Things (IoMT), which is governed by several critical factors. This growth is attributed to the rising demand for telehealth solutions, rising technological advancements, and increasing investments in the healthcare sector.

In rural regions of the Asia-Pacific, where access to healthcare facilities is often limited, telehealth platforms are increasingly gaining traction. IoMT devices enable healthcare providers to deliver care remotely, significantly enhancing access to healthcare services for underserved populations. For instance, in November 2024, MedAdvisor Solutions, MedAdvisor Solutions launched a Telehealth Service on MedAdvisor Patient App. Access to telehealth services was ranked as the 3rd most desirable feature by pharmacists, based on feedback from our extensive network of pharmacy partners. Telehealth access via the App simplifies the patient healthcare journey, allowing patients to consult with providers and manage their prescriptions from anywhere, at any time.

By leveraging these technologies, healthcare professionals can reach patients who might otherwise face barriers to receiving timely medical attention, thereby improving overall health outcomes in these communities. This trend is particularly is emerging in countries like India and China, where substantial portions of the population reside in remote areas.

Competitive Landscape

The major global players in the Internet of Medical Things (IoMT) market include Boston Scientific Corporation, Koninklijke Philips N.V., GE HealthCare, Siemens Healthineers International AG, Medtronic, Honeywell International Inc., Johnson & Johnson, Abbott, ResMed, BIOTRONIK among others.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global Internet of Medical Things (IoMT) market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Component
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising demand for wearable devices
- 4.1.2. Restraints
  - 4.1.2.1. Regulatory challenges
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Component

6.1. Introduction
- 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Component
- 6.1.2. Market Attractiveness Index, By Component
6.2. Hardware*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 6.2.3. Wearable Devices
- 6.2.4. Stationary Devices
- 6.2.5. Implantable Devices
- 6.2.6. Others
6.3. Software
- 6.3.1. Device Management
- 6.3.2. Application Management

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Telemedicine*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Clinical Operations & Workflow Management
7.4. Smart Labs
7.5. Patient Monitoring
7.6. Remote Patient Monitoring
7.7. Healthcare Devices
7.8. Heart-rate Monitoring
7.9. Others

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Healthcare Providers*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Homecare
8.4. Clinics
8.5. Research Institutes
8.6. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Boston Scientific Corporation*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Koninklijke Philips N.V.
11.3. GE HealthCare
11.4. Siemens Healthineers International AG
11.5. Medtronic
11.6. Honeywell International Inc.
11.7. Johnson & Johnson
11.8. Abbott
11.9. ResMed
11.10. BIOTRONIK (LIST NOT EXHAUSTIVE)